2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 26 (9) , 2488-2500
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund (1)
This publication has 41 references indexed in Scilit:
- Malaria medicines: a glass half full?Nature Reviews Drug Discovery, 2015
- Recent Advances in Plasmepsin Medicinal Chemistry and Implications for Future Antimalarial Drug Discovery EffortsCurrent Topics in Medicinal Chemistry, 2012
- New medicines to improve control and contribute to the eradication of malariaNature Reviews Drug Discovery, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Drug‐resistant malaria − an insightThe FEBS Journal, 2007
- Achiral, Cheap, and Potent Inhibitors of Plasmepsins I, II, and IVChemMedChem, 2006
- Plasmepsins as potential targets for new antimalarial therapyMedicinal Research Reviews, 2006
- Potent Inhibitors of the Plasmodium falciparum Enzymes Plasmepsin I and II Devoid of Cathepsin D Inhibitory ActivityJournal of Medicinal Chemistry, 2003
- Design and Synthesis of Plasmepsin I and Plasmepsin II Inhibitors with Activity in Plasmodium falciparum-Infected Cultured Human ErythrocytesJournal of Medicinal Chemistry, 2003
- Potent, Low-Molecular-Weight Non-Peptide Inhibitors of Malarial Aspartyl Protease Plasmepsin IIJournal of Medicinal Chemistry, 1999